AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
about
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesisModulation of Autophagy by Sorafenib: Effects on Treatment ResponseMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursHydrogen peroxide - production, fate and role in redox signaling of tumor cellsSodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinasep53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signalingAcadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell deathMulti-target drugs: the trend of drug research and developmentCompound C prevents the unfolded protein response during glucose deprivation through a mechanism independent of AMPK and BMP signalingAMPK activators suppress cervical cancer cell growth through inhibition of DVL3 mediated Wnt/β-catenin signaling activityHistological evaluation of AMPK signalling in primary breast cancerMEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in miceMevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cellsAMP-activated protein kinase regulates intraocular pressure, extracellular matrix, and cytoskeleton in trabecular meshwork.Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathwayActivation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.Establishing a relationship between prolactin and altered fatty acid β-oxidation via carnitine palmitoyl transferase 1 in breast cancer cells.Risk of gastric cancer is associated with PRKAA1 gene polymorphisms in Koreans.Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP).AMPK-Dependent Metabolic Regulation by PPAR Agonists.LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cellsAdiponectin modulates C-jun N-terminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma.Arctigenin enhances swimming endurance of sedentary rats partially by regulation of antioxidant pathways.The LKB1 tumor suppressor controls spindle orientation and localization of activated AMPK in mitotic epithelial cells.Tumor Suppressor Serine/Threonine Kinase LKB1 Expression, Not Kinase Activity, Increased in the Vascular Smooth Muscle Cells and Neointima in the Rat Carotid Artery Injury ModelThe Caenorhabditis elegans AMP-activated protein kinase AAK-2 is phosphorylated by LKB1 and is required for resistance to oxidative stress and for normal motility and foraging behavior.AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemiaA comprehensive analysis of adiponectin QTLs using SNP association, SNP cis-effects on peripheral blood gene expression and gene expression correlation identified novel metabolic syndrome (MetS) genes with potential role in carcinogenesis and systemDNA replication stress, genome instability and aging.AMP-activated protein kinase suppresses matrix metalloproteinase-9 expression in mouse embryonic fibroblasts.Gerosuppressant metformin: less is moreSuppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cellsCandidate mechanisms accounting for effects of physical activity on breast carcinogenesis.Function of CD147 in atherosclerosis and atherothrombosisDietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta.Metabolic Syndrome and Breast Cancer Risk: Is There a Role for Metformin?Lipid abnormalities in alpha/beta2-syntrophin null mice are independent from ABCA1.Cilostazol Inhibits Vascular Smooth Muscle Cell Proliferation and Reactive Oxygen Species Production through Activation of AMP-activated Protein Kinase Induced by Heme Oxygenase-1.Hispidulin enhances the anti-tumor effects of temozolomide in glioblastoma by activating AMPK.
P2860
Q24614006-458ECC70-90F5-4B9A-A902-240917D77CA3Q26745320-66910E27-D37E-46F3-9A54-CC9E10F2AEEFQ26751659-6ADC29E7-2A7D-49D1-A5E1-383051313860Q26787065-65467811-E85C-4CCA-87F8-44EFCAA65BA5Q27339789-C3DD5A7F-C014-49F1-9CFD-7F6F64397407Q28117922-F080AA34-E60D-492C-8278-F0C429B73511Q28471941-D34A6C24-594F-44CD-ABDF-76C3270383B6Q28480888-6390CD5F-B1F3-41A8-9121-AEA97CD9EAC3Q28483959-39E09E6B-D317-45FC-AAB9-5CAEA3122E9FQ28484795-E626F804-412A-450D-88DE-3272B2312512Q33499119-B4198BCA-4EAE-4E58-AE86-16EC33EEF456Q33521236-7B8BE9DA-15F9-45FF-BC1E-41D6A4DD765AQ33566705-01164073-9C6D-450E-9146-CF12A86A59F2Q33621882-DC47CB8C-0C93-4AC8-AEC5-58B3F96827CCQ33718319-792D01CA-4D92-43C7-A46A-2C46FCB9F7D8Q33727103-157E097F-F6D7-47FD-84CA-3250665F86D9Q33812119-BD037F54-C9E1-49AE-AD72-0D69457FCF9BQ33887047-C824D3A8-80F1-4131-98CF-6A7BCCE89AA7Q34052614-00AE81C8-56F8-42FF-BAD3-DA7D8D4B1E9BQ34071260-32FB96D5-75A1-44E9-9649-6784011F3FB4Q34089730-D6736227-8C8C-4A15-BF59-4FAA70F18265Q34155989-77069FE5-354C-41A4-B170-5172E102DFA5Q34258684-E25E79B0-472F-4881-B814-8A9D36D9AFBDQ34295032-0FEE4CEE-7049-4C83-B310-A93772E61984Q34345692-D5E62605-0358-401C-90F7-2E523A812285Q34434684-D5001C5B-B7F1-4AEE-A73F-8BE833716A86Q34590433-F593491D-44AC-4253-8ABF-E2E35D886122Q34647789-FAD376FE-474A-4F80-9FD6-5CB268234B33Q34694696-0626ABC5-2065-4ACE-A8D5-47687DBD3E28Q34720959-4A85C568-F21A-4D45-8623-6B53BDE4CB7FQ34963339-0CBA19E5-EA3A-4E54-A3C4-7B02A5E9386AQ35052060-5354792B-F81B-4B1F-89BA-BB1EF3B5DF85Q35110805-A5326AC1-D0B5-43DF-AB38-716B780C8618Q35137058-856B32AC-BB44-43BD-90C6-FB193C7DB108Q35152073-8BED4A42-B087-4C76-ABDB-5E4270473B03Q35159373-5A700D10-F24D-4C73-A936-D0264E7C3DE9Q35161241-93AD4D74-720D-4F8B-BF47-EE7F26750402Q35186664-EFDD723D-E326-4EBF-9BB8-BC31719EB215Q35270041-3DDCC5C5-3DB6-4E50-9F97-9F7294169549Q35332213-0AC0EEE4-21C8-42D2-AB4C-95A4C891AD77
P2860
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@ast
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@en
type
label
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@ast
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@en
prefLabel
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@ast
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@en
P2093
P2860
P1476
AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer.
@en
P2093
Barry J Goldstein
Eiichi Araki
Hiroyuki Motoshima
Motoyuki Igata
P2860
P356
10.1113/JPHYSIOL.2006.108324
P407
P577
2006-04-13T00:00:00Z